The abstract is read at the publisher; the summary is JClub's.
B3GNT9 is significantly upregulated in glioblastoma tumor cells in the peritumoral brain zone (PBZ), and its high expression is linked to poor prognosis.
- Why it matters: GBM recurrence and invasion in the PBZ drive spread, but the molecular program that reprograms metabolism to support invasion is not well defined.
- What they did: Using RNA-seq of tumor core and PBZ tissues, then functional tests in glioblastoma cell lines, patient-derived cells, and animal models, the study mapped a B3GNT9→PPARD→ACOX1 pathway. It showed B3GNT9 increases mucin-type O-glycosylation that enhances PPARD activity and ACOX1 expression, reducing intracellular eicosapentaenoic acid (EPA) levels.
- The result: Activation of the B3GNT9-PPARD-ACOX1 axis reduces intracellular EPA and promotes GBM invasiveness, suggesting targeting this axis could suppress invasion and recurrence.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.